Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...

We recently published a list of Jim Cramer Says You Should Buy These 10 Stocks. Since Eli Lilly & Co (NYSE:LLY) ranks 3rd on ...

Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on Microsoft (MSFT), ...

Eli Lilly stock has soared, but investment bank analysts who follow the drugmaker think it can climb higher. According to ...

ResMed (RDM) remains attractive despite a recent selloff driven by positive sleep data for Eli Lilly's (LLY) GLP-1, ...

Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.

We believe that Eli Lilly stock (NYSE: LLY) is currently a better pick than its industry peer – Pfizer stock , given its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced ...

Eli Lilly (NYSE: LLY) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity ...

A JAMA Internal Medicine study published Monday found that the active ingredient in Eli Lilly's Mounjaro and Zepbound caused ...